Insulet Corporation (PODD) Revenue by Segment
Insulet revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 30, 2026), Insulet's largest product or service was U.S. Omnipod, with $544.10 million or 68% of revenue, up 20.1% from a year earlier. Next: International Omnipod (31%) and Drug Delivery (1%).
By region, United States brought in 69% and Non-US brought in 31% of revenue in Q2 fiscal 2026.
By country, UNITED STATES brought in 69% and Non-US brought in 31% of revenue in Q2 fiscal 2026.
The fastest-growing product or service from a year earlier was International Omnipod (+35.5%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.
Insulet Corporation
Revenue breakdown
Fiscal quarters, from company filings
Insulet revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| U.S. Omnipod | $544.1M | – | $497.1M | $453.2M | 68% |
| International Omnipod | $251.8M | – | $202.1M | $185.8M | 31% |
| Drug Delivery | $5.8M | $3.3M | $7.1M | $10.2M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Insulet revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $549.9M | $518.8M | $504.2M | $463.3M | 69% |
| Non-US | $251.8M | $242.9M | $202.1M | $185.8M | 31% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Insulet revenue by country, last 4 quarters
| Country | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| UNITED STATES | $549.9M | $518.8M | $504.2M | $463.3M | 69% |
| Non-US | $251.8M | $242.9M | $202.1M | $185.8M | 31% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
Which product or service makes the most money for Insulet?
U.S. Omnipod: $544.10 million, or 68% of revenue, in Q2 fiscal 2026.
What are Insulet's main products and services?
By revenue in Q2 fiscal 2026: U.S. Omnipod (68%), International Omnipod (31%) and Drug Delivery (1%).
Where does Insulet make its money?
By region in Q2 fiscal 2026: United States (69%) and Non-US (31%).
